Merck Dirección
Dirección controles de criterios 3/4
El CEO de Merck es Rob Davis , nombrado en Apr 2021, tiene una permanencia de 3.58 años. compensación anual total es $20.27M, compuesta por 7.9% salario y 92.1% primas, incluidas acciones y opciones de la empresa. posee directamente un 0.014% de las acciones de la empresa, por valor de $34.55M. La antigüedad media del equipo directivo y de la junta directiva es de 3.8 años y 5.2 años, respectivamente.
Información clave
Rob Davis
Chief Executive Officer (CEO)
US$20.3m
Compensación total
| Porcentaje del salario del CEO | 7.9% |
| Permanencia del CEO | 3.6yrs |
| Participación del CEO | 0.01% |
| Permanencia media de la dirección | 3.8yrs |
| Promedio de permanencia en la Junta Directiva | 5.2yrs |
Actualizaciones recientes de la dirección
Recent updates
The Strong Earnings Posted By Merck (NYSE:MRK) Are A Good Indication Of The Strength Of The Business
Nov 15
Merck: Keytruda's Sales Projections Outweigh Competitive And Patent Risks
Nov 14Merck: An Undervalued Dividend Machine
Nov 07Merck Q3 Earnings Review: Solid Financials May Be Undermined By New Keytruda Threat
Oct 25Market Still Lacking Some Conviction On Merck & Co., Inc. (NYSE:MRK)
Oct 15Merck Is At Support And Should Go Higher (Technical Analysis)
Oct 07Merck Appears Ready To Return To June Highs (Technical Analysis)
Sep 14Merck's Change To Profit Guidance Provides An Opportunity
Sep 01Análisis de compensación del CEO
| Fecha | Compensación total | Salario | Ingresos de la empresa |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | US$12b |
| Jun 30 2024 | n/a | n/a | US$14b |
| Mar 31 2024 | n/a | n/a | US$2b |
| Dec 31 2023 | US$20m | US$2m | US$365m |
| Sep 30 2023 | n/a | n/a | US$5b |
| Jun 30 2023 | n/a | n/a | US$3b |
| Mar 31 2023 | n/a | n/a | US$13b |
| Dec 31 2022 | US$19m | US$2m | US$15b |
| Sep 30 2022 | n/a | n/a | US$15b |
| Jun 30 2022 | n/a | n/a | US$17b |
| Mar 31 2022 | n/a | n/a | US$14b |
| Dec 31 2021 | US$14m | US$1m | US$12b |
| Sep 30 2021 | n/a | n/a | US$6b |
| Jun 30 2021 | n/a | n/a | US$4b |
| Mar 31 2021 | n/a | n/a | US$5b |
| Dec 31 2020 | US$7m | US$1m | US$5b |
| Sep 30 2020 | n/a | n/a | US$9b |
| Jun 30 2020 | n/a | n/a | US$9b |
| Mar 31 2020 | n/a | n/a | US$9b |
| Dec 31 2019 | US$8m | US$1m | US$6b |
| Sep 30 2019 | n/a | n/a | US$9b |
| Jun 30 2019 | n/a | n/a | US$9b |
| Mar 31 2019 | n/a | n/a | US$8b |
| Dec 31 2018 | US$7m | US$1m | US$6b |
| Sep 30 2018 | n/a | n/a | US$3b |
| Jun 30 2018 | n/a | n/a | US$1b |
| Mar 31 2018 | n/a | n/a | US$2b |
| Dec 31 2017 | US$6m | US$1m | US$2b |
Compensación vs. Mercado: La compensación total de Rob($USD20.27M) está por encima de la media de empresas de tamaño similar en el mercado US ($USD12.66M).
Compensación vs. Ingresos: La compensación de Rob ha sido consistente con los resultados de la empresa en el último año.
CEO
Rob Davis (57 yo)
3.6yrs
Permanencia
US$20,273,287
Compensación
Mr. Robert M. Davis, also known as Rob, J. D., is Chief Executive Officer and Director at Merck & Co., Inc. since July 1, 2021 and is Chairman from December 01, 2022. He serves as President at Merck & Co.,...
Equipo directivo
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| Chairman | 3.6yrs | US$20.27m | 0.014% $ 34.5m | |
| Executive VP & CFO | 3.6yrs | US$8.30m | 0.0020% $ 5.0m | |
| Executive VP & President of Merck Animal Health | 13.2yrs | US$6.20m | 0.0060% $ 15.0m | |
| Executive VP & President of Merck Manufacturing Division | 15yrs | US$6.24m | 0.0062% $ 15.6m | |
| Executive VP & President of Merck Research Laboratories | 7yrs | US$9.78m | 0.0018% $ 4.6m | |
| Senior VP of Finance | less than a year | sin datos | 0.00018% $ 451.6k | |
| Executive VP and Chief Information & Digital Officer | no data | sin datos | 0.00079% $ 2.0m | |
| Vice President of Investor Relations | 5.3yrs | sin datos | sin datos | |
| Executive VP & General Counsel | 6.6yrs | US$5.90m | 0.0012% $ 2.9m | |
| Executive VP and Chief Communications & Public Affairs Officer | 3.3yrs | sin datos | sin datos | |
| Executive VP & Chief Human Resources Officer | less than a year | sin datos | sin datos | |
| Senior VP & President Merck U.S. Human Health | 3.8yrs | sin datos | 0.00094% $ 2.4m |
3.8yrs
Permanencia media
56yo
Promedio de edad
Equipo directivo experimentado: El equipo directivo de MRK se considera experimentado (3.8 años antigüedad media).
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| Chairman | 3.3yrs | US$20.27m | 0.014% $ 34.5m | |
| Independent Director | 9.2yrs | US$400.00k | 0.000070% $ 175.6k | |
| Independent Director | 29.2yrs | US$360.00k | 0.00052% $ 1.3m | |
| Independent Lead Director | 17yrs | US$430.10k | 0.00020% $ 501.8k | |
| Independent Director | 4.5yrs | US$365.00k | 0.000040% $ 100.4k | |
| Independent Director | 2.5yrs | US$347.64k | 0.000040% $ 100.4k | |
| Independent Director | 6.7yrs | US$340.00k | 0% $ 0 | |
| Independent Director | 3.7yrs | US$350.00k | 0% $ 0 | |
| Independent Director | 4.7yrs | US$350.00k | 0.000020% $ 50.2k | |
| Independent Director | 4.7yrs | US$350.00k | 0% $ 0 | |
| Independent Director | 9.2yrs | US$380.00k | 0% $ 0 | |
| Independent Director | 5.7yrs | US$342.36k | 0% $ 0 |
5.2yrs
Permanencia media
65.5yo
Promedio de edad
Junta con experiencia: La junta directiva de MRK se considera experimentada (5.2 años de antigüedad promedio).